Sebastiaan O.
- Country
- The Netherlands
- Department
- Neurology
Research Overview
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Trial of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Trial of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 2
- Evaluation of Cannabidiol on Sleep Quality in Multiple Sclerosis Patients with Insomnia: A Randomized, Placebo-Controlled N-of-1 Trial Series
Data & Insights
Has run more than one trial at 21 of 30 partner sites.
Specializations
Sleep Medicine
The investigator specializes in studying sleep disorders and their impact on neurological conditions, with particular emphasis on developing therapeutic interventions for insomnia.
- Sleep Quality Assessment
- Sleep Pattern Analysis
- Sleep Disorder Management
Research focuses on understanding sleep disturbances in patients with complex medical conditions.
Neurological Disorders
Dedicated to investigating therapeutic approaches for Multiple Sclerosis patients, particularly addressing associated sleep complications and quality of life improvements.
- MS-Related Sleep Disorders
- Neurological Sleep Patterns
- Quality of Life Assessment
Explores the intersection between neurological conditions and sleep health.
Alternative Therapeutics
Investigates the application of cannabinoid-based treatments for sleep disorders, focusing on their potential benefits in managing sleep disturbances.
- CBD Applications
- Sleep Medicine Innovation
- Treatment Development
Explores novel therapeutic approaches for complex sleep disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.